Status:
COMPLETED
French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS)
Lead Sponsor:
ResMed
Conditions:
Chronic Heart Failure
Central Sleep Apnea
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of FACE study is to provide in routine practice complementary long-term data on the mortality and morbidity of Chronic Heart Failure (CHF) patients with Central Sleep Apnea eligible for Ad...
Detailed Description
The prevalence of Central Sleep Apnea (CSA) and/or Cheyne-Stokes Respiration (CSR) in patients with Chronic Heart Failure (HF) is 15-46% and it is associated with worse prognosis. Adaptative Servo-Ven...
Eligibility Criteria
Inclusion
- Adult Patient with Chronic Heart Failure
- Central Sleep Apnea requiring ASV therapy
Exclusion
- Contra-indications to ASV therapy
- Respiratory Failure or Hypercapnia inconsistent with ASV therapy
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
509 Patients enrolled
Trial Details
Trial ID
NCT01831128
Start Date
November 1 2009
End Date
September 1 2020
Last Update
February 2 2021
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical practice of cardiology
Amnéville, France, 57360
2
Angers University Hospital
Angers, France, 49100
3
Antibes Hospital
Antibes, France, 06160
4
Béziers Hospital
Béziers, France, 34500